Skip to main content
. 2020 Dec 14;15:10183–10197. doi: 10.2147/IJN.S282931

Figure 6.

Figure 6

Ability of PDA-SN38@SCM NPs to target cancer cells. (A) CLSM images of MG63 cells treated with free SN38, PDA-SN38 NPs or PDA-SN38@SCM NPs for 4 h. Scale bar = 10 μm. (B) Cell-uptake efficiency of different SN38 formulations by flow cytometry.